Transcell Biologics is developing a technology called DART, or Digital Animal Replacement Technology, to improve the predictability of molecular discoveries in the pharmaceutical industry. This initiative aims to bridge the gap between initial molecular findings and their actual impact on human biology. AI
IMPACT This technology aims to improve drug discovery and development by enhancing the predictability of molecular interactions in humans.
RANK_REASON The item describes a specific technology developed by a company, which falls under the 'tool' category as it's not a frontier release, significant industry move, or academic research.
Read on Mastodon — fosstodon.org →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
